Martin Ventures

Martin Ventures is a Nashville-based single-family office and healthcare-focused venture capital firm founded in 2009 by Charlie Martin, a veteran healthcare executive with more than 50 years of experience operating large, complex healthcare systems. Unlike traditional venture funds, the firm invests its own capital rather than managing external LP money, enabling a patient, long-term investment approach unconstrained by fund cycles. The firm's mandate covers healthcare technology, healthcare services, and tech-enabled healthcare services that optimize provider businesses, develop innovative care models, and empower consumers — explicitly avoiding medical devices and biotech requiring regulatory approval. Martin Ventures typically writes $1 million to $3 million checks into companies with $2 million or more in ARR and strong growth trajectories, and leads rounds. Across 108 total investments, the portfolio has produced 2 unicorns, 1 IPO (Amwell), and 22 acquisitions including Ovia Health and Cedar. Recent investments include ArcheHealth ($6.7 million seed in June 2025) and Harbor Health (clinics and outpatient care, September 2025). Martin Ventures also serves as the primary funding source for ROND Capital, a private equity firm, and Medical Properties of America, a healthcare REIT. The firm operates a shared-service advisory company and a boutique consulting practice that provide operational support and mentoring to portfolio entrepreneurs alongside capital. Charlie Martin's five decades of healthcare operating experience gives portfolio founders direct access to a leader who has built and led institutions across the healthcare system — a resource that pure financial investors rarely offer. The firm's deliberate focus on revenue-generating, technology-enabled healthcare companies reflects a disciplined effort to back companies at the moment they are ready to scale commercially rather than betting on regulatory or clinical outcomes.